Semaglutide is contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), history of pancreatitis, pregnancy or breastfeeding, and severe gastrointestinal disorders such as gastroparesis
These findings do not seem to be specific for GH, but rather for hyperthyroidism in general, having been observed also in patients with subclinical hyperthyroidism due to multinodular goiter (31)
For us as clinicians, the 2035 projections map directly onto the chronic disease burden we'll be managingmore diabetes, more cardiovascular disease, more musculoskeletal disease, more Alzheimer's, and higher costs across the board
Limitations in the current study should be noted
Ohue, Y